Assorted News from the Last Week: Penn State students have raised more than $16.9 million for pediatric cancer patients in the annual 46-hour dance marathon

Assorted News from the Last Week: A Belgian boy with DIPG has lived seven years after his diagnosis and now at 13 years old, there

Assorted News from the Last Week: The National Comprehensive Cancer Network® (NCCN®) published its first ever set of treatment recommendations pertaining to neuroblastoma. Replacing brentuximab

Assorted News from the Last Week: Hispanic population appears underrepresented in pediatric cancer trials. Liquid biopsies to monitor therapy success and to predict the recurrence

Assorted News from the Last Week: A year after an investigation revealed widespread use of a substandard version of asparaginase, the World Health Organization and

Assorted News from the Last Week: The Coalition Against Childhood Cancer (CAC2) takes great pride in introducing its groundbreaking CAC2 Survivorship Toolkit. Training that increases

Assorted News from the Last Week: The Coalition Against Childhood Cancer (CAC2) takes great pride in introducing its groundbreaking CAC2 Survivorship Toolkit. Scientists found that

Welcome to 2024 and the 201st edition of the CAC2 Childhood Cancer Community News Digest! Assorted News from the Last Week: The FDA granted a

For many, the holiday season is a time of joy, togetherness, and reflection. However, families dealing with the harsh reality of pediatric cancers face exceptional

Assorted News from the Last Week: CAC2 Members Nicole Scobie (Zoe4Life) and Nick Bird (Solving Kids’ Cancer-UK) contributed to this Journal of Clinical Oncology commentary